The effect of contrast agents on the anticoagulant properties of oral factor Xa inhibitors

CONCLUSION: The anticoagulant properties of rivaroxaban and edoxaban tended to increase significantly, but there was no statistically significant difference in the anticoagulant properties of apixaban after the administration of contrast agent. To determine whether the small laboratory difference has a clinical effect, there is a need for larger clinical trials (NCT04611386).PMID:35296141 | DOI:10.1177/02841851221081474

Source: Acta Radiologica - March 17, 2022 Category: Radiology Authors: Burcu Cavlan Selma Ari Hasan Ari Sencer Çamci Mehmet Melek Tahsin Bozat Source Type: research